Tetrandrine enhances anti-PD-1 immunotherapeutic efficacy for hepatocellular carcinoma by activating STING/TBK1/IRF3 pathway. - Zheng B; Yao G; Pang Y; Luo J; Yang Z; Xiu F; Zhen C; Liang R (Frontiers in immunology, 2026)